MAT for Adolescents with Opioid Use Disorder
MEDICATION ASSISTED TREATMENT ECHO
This interactive web-based program provides essential guidelines and steps to implementing and integrating a successful MAT program into an outpatient primary care setting. The MAT program aims to improve access for patients suffering from opioid use disorder.
- Diagnosing Opioid Use Disorder
- Types of medications (naltrexone vs. buprenorphine) and requirements for each (labs, monitoring, etc.)
- Buprenorphine induction maintenance, relapse and tapering protocols
- Referral process, clinic flow
- Opiate withdrawal-treatment
- Drug screens
- Controlled substance agreement
- Multi-party consents
- Prior authorization requirements for buprenorphine (documentation, barriers, etc.)
- Clinic and community integration
The purpose is to inform clinic members (admin, providers, nursing, etc.) on how to successfully integrate a MAT program into an outpatient primary care setting. The mission is to help centers and clinics set up primary care based MAT to improve access for patients suffering from opioid use disorder across the state of Iowa.
Professional Practice Gap
There is a lack of resources, expertise and time for learning the integration of MAT within a primary care setting. By providing access to example protocols, clinic flow and other measures to improve integration, this will decrease the burden of the work required to start a program.
- Provide essential guidelines and steps to implement a successful MAT program into primary care setting.
- Improve access for patients suffering from opioid use disorder.
- Provide an overview of MAT use with adolescent patients.
Gagan Lamba, MA, MS, MBA, CSM
Iowa Primary Care Association
Iowa Primary Care Association
Relevant to the content of this educational activity, the moderators have no financial relationships with commercial interest companies to disclose.
Alison Lynch, MD, MS
Department of Family Medicine, University of Iowa Carver College of Medicine
Director, Addiction Medicine
Director, Opioid Addiction Clinic
Associate Program Director, Combined Family Medicine/Psychiatry Residency Program
Clinical Professor of Psychiatry
Clinical Professor of Family Medicine
- BS, Chemistry and Science, Technology & Society, Massachusetts Institute of Technology, Cambridge, MA
- Teach for America Summer Institute, Los Angeles, CA
- MD, University of Iowa College of Medicine, Iowa City, IA
- MS, Health Care Delivery Science, Dartmouth College, Hanover, NH
- Resident, Combined Residency Program in Family Medicine and Psychiatry, University of Iowa Hospitals and Clinics, Iowa City, IA
Licensure and Certifications
- Public and Community Psychiatry- American Association of Community Psychiatrists
- Buprenorphine MAT Waiver Trainer - American Psychiatric Association
- Psychiatry Certification- American Board of Psychiatry and Neurology
- Medical License - Iowa Board of Medicine
- Family Medicine Certification- American Board of Family Medicine
Relevant to the content of this education activity, the speaker indicated they do not have a financial relationships with commercial interest companies to disclose.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.25 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and Primary Health Care, Inc. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 1.25 continuing education contact hour(s). No partial credit awarded.
- Other healthcare professionals: This live activity is designated for 1.25 AMA PRA Category 1 Credit(s)TM.
No commercial interest provided financial support for this continuing education activity.
Relevant to the content of this educational activity, the planning committee members and speaker indicated they have no financial relationships with commercial interests to disclose. The speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas.
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 1.25 AMA PRA Category 1 Credits™
- 1.25 AOA Category 2A
- 1.25 CE Contact Hour(s)
- 1.25 IBON